The Veterans Administration estimates 17 U.S. veterans die by suicide each day on average. Behind many of those deaths is PTSD. Now, there's growing optimism about how technology is improving ...

In a show of bipartisanship, 80 members of Congress from both sides of the aisle have united in letters urging President Joe Biden and the US Food and Drug Administration to further consider studies ...

This mental health condition can turn your life into a mess in more ways than one. The good news is that there are a range of PTSD treatment options available. But before getting into the options ...

Experiencing trauma can sometimes lead to post-traumatic stress disorder (PTSD). This serious mental health condition is marked by changes in mood, intrusive memories, avoidant behavior, and a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Improved management of post-traumatic stress disorder ...

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.

Commonly known as an anesthetic, recent studies highlight the potential for ketamine to offer fast relief from PTSD and anxiety symptoms where traditional therapies fall short. Ketamine can be ...

In the United States, at least 17 veterans lose their lives to suicide each day. This is a gut-wrenching reminder that the horrors of war are not always left on the battlefield and often haunt ...

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. (Manuel Balce Ceneta/AP) Federal health regulators on Friday declined to approve the psychedelic drug ...

Today, I’m writing from the cutting-edge of innovation and research in PTSD. PTSD science continues to advance exponentially, and exciting breakthroughs are on the horizon. What I’m presenting in this ...

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.